[引用][C] Kronik myeloid lösemi ve akut lenfoblastik ön tanılı olgularda konvensiyonel sitogenetik ve floresan in situ hibridizasyon ile analizler
HG Akyar - Sağlık Bilimleri Enstitüsü
How we monitor the therapy effectiveness in patients with chronic myeloid leukemia-A Single center experience
S Mešanović, A Žugić-Jahić, S Hasić, V Simendić… - Genetics & …, 2023 - genapp.ba
Chronic myeloid leukemia (CML) is a hematological disorder characterized by increased
proliferation of the granulocytic cell lineage. We diagnose CML by presence of the …
proliferation of the granulocytic cell lineage. We diagnose CML by presence of the …
Monitoring Response to Imatinib by Fluorescence In Situ Hybridization (FISH) and Real-Time Quantitative Polymerase Chain Reaction (RQ-PCR) in Chronic Myeloid …
IA Giere, C Pavlovsky, MV Lombardi, P Negri… - 2006 - ashpublications.org
Introduction: The evaluation of response to imatinib in CML patients (pts) as guide to clinical
management is undergoing substantial changes of criteria. The degree of reduction of total …
management is undergoing substantial changes of criteria. The degree of reduction of total …
[PDF][PDF] Valutazione molecolare nella leucemia mieloide cronica
B Izzo, R Accetta, S Caruso, B De Angelis… - biochimica …, 2015 - biochimicaclinica.it
Molecular monitoring in chronic myeloid leukemia (CML). The pathognomonic genetic
alteration in CML is the formation of the BCR-ABL fusion gene, which produces a …
alteration in CML is the formation of the BCR-ABL fusion gene, which produces a …
Chronic Myeloid Leukemia: from Therapy Monitoring to Personalized Medicine. Assessment of Industrial Process
P GONZALEZ RUIZ - 2017 - tesidottorato.depositolegale.it
Abstract Introduzione: La Leucemia Mieloide Cronica (LMC) è un disordine
mieloproliferativo delle cellule staminali pluripotenti caratterizzato per la presenza del gene …
mieloproliferativo delle cellule staminali pluripotenti caratterizzato per la presenza del gene …
[PDF][PDF] The Impact of Cytogenetic Aberrations in the Clonal Evolution of Chronic Myeloid Leukemia: A Single-Center Experience Among 450 Turkish Patients (Cohort …
Objective: Chronic myeloid leukemia (CML) is a clonal hematologic disorder characterized
by t (9; 22) translocation, in which cytogenetic aberrations can occur in Ph (+) and (-) clones …
by t (9; 22) translocation, in which cytogenetic aberrations can occur in Ph (+) and (-) clones …
[引用][C] İlaç direnci gelişen kronik myeloid lösemi olgularında bcr-abl1 t3151 mutasyonları ve ahı1 gen ifadelenme düzeylerinin belirlenmesi
T Bulakbaşı Balcı - 2009 - Başkent Üniversitesi Tıp Fakültesi
Molecular analysis of hematopoietic colonies derived from chronic myeloid leukemia patients: interphase fluorescence in situ hybridization compared with RT-PCR
SFT Thijsen, GJ Schuurhuis, JW Van Oostveen… - Leukemia, 1997 - nature.com
In this study we compared interphase fluorescence in situ hybridization (I-FISH) with reverse
transcription polymerase chain reaction (RT-PCR) for the molecular analysis of …
transcription polymerase chain reaction (RT-PCR) for the molecular analysis of …
[PDF][PDF] Molekulární genetika v diagnostice a léčbě chronické myeloidní leukemie
KM Poláková, K Zemanová, M Součková, A Broučková… - casopisvnitrnilekarstvi.cz
This overview discusses an importance of molecular diagnostics of chronic myeloid
leukemia, molecular monitoring of treatment efficacy, residual disease and resistance to …
leukemia, molecular monitoring of treatment efficacy, residual disease and resistance to …
[HTML][HTML] Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid …
IS Pagani, O Spinelli, E Mattarucchi, C Pirrone… - …, 2014 - ncbi.nlm.nih.gov
Imatinib mesylate (IM) is the first line therapy against Chronic Myeloid Leukemia, effectively
prolonging overall survival. Because discontinuation of treatment is associated with relapse …
prolonging overall survival. Because discontinuation of treatment is associated with relapse …